Hematrack: High sensitivity measurable residual disease (MRD) monitoring in acute lymphoblastic leukemia with NGS
Saved in:
Main Authors: | Vineeth Surendranath (Author), Claudia Pahlke (Author), Thomas Lingl (Author), Tom Kasper (Author), Madlen Pahlke (Author), Pritha Dasgupta (Author), Cornelia Eckert (Author), Ulf-Peter Guenther (Author), Vaskar Saha (Author), Vinzenz Lange (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PCR-based MRD testing for acute lymphoblastic leukaemia in India
by: Rubina Islam, et al.
Published: (2017) -
Aberrant TP53 pathways regulate leukaemic cell survival in acute lymphoblastic leukaemia
by: Pritha Paul, et al.
Published: (2017) -
Steuerbedarf und Geldpolitik in der wachsenden Wirtschaft. Geldschöpfung als Mittel der Staatsfinanzierung
by: Pahlke, Jürgen
Published: (1970) -
Standardization of 13-color high-sensitivity measurable residual disease (MRD) assessment in B-cell lymphoblastic leukemia (B-ALL) treated with novel anti-CD19 immunotherapies
by: Prashant Tembhare, et al.
Published: (2022) -
Evolving strategies in the management of relapsed acute lymphoblastic leukaemia - TMCKidsALLR1
by: Prakriti Roy, et al.
Published: (2017)